Integrated Advisors Network’s AbbVie ABBV Stock Holding History

Integrated Advisors Network’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.8M	Sell	46,747 -762	-2%	-$164K	0.54%	38
2026 Q1	$10.3M	Buy	47,509 +11,057	+30%	+$2.45M	0.54%	38
2025 Q4	$8.33M	Buy	36,452 +37	+0.1%	+$8.43K	0.37%	59
2025 Q3	$8.43M	Sell	36,415 -416	-1%	-$84.7K	0.35%	62
2025 Q2	$6.84M	Sell	36,831 -16,627	-31%	-$3.09M	0.31%	78
2025 Q1	$11.2M	Buy	53,458 +10,856	+25%	+$2.11M	0.57%	31
2024 Q4	$7.57M	Buy	42,602 +208	+0.5%	+$38.2K	0.36%	61
2024 Q3	$8.37M	Sell	42,394 -2,784	-6%	-$520K	0.4%	54
2024 Q2	$7.75M	Sell	45,178 -628	-1%	-$104K	0.4%	51
2024 Q1	$8.34M	Sell	45,806 -207	-0.4%	-$35.7K	0.42%	54
2023 Q4	$7.13M	Sell	46,013 -1,144	-2%	-$167K	0.4%	60
2023 Q3	$7.03M	Buy	47,157 +611	+1%	+$89.7K	0.43%	50
2023 Q2	$6.27M	Buy	46,546 +981	+2%	+$144K	0.36%	63
2023 Q1	$7.26M	Sell	45,565 -23,864	-34%	-$3.65M	0.44%	52
2022 Q4	$11.2M	Buy	69,429 +11,654	+20%	+$1.79M	0.72%	28
2022 Q3	$7.75M	Sell	57,775 -19,591	-25%	-$2.81M	0.53%	39
2022 Q2	$11.8M	Sell	77,366 -1,096	-1%	-$167K	0.77%	24
2022 Q1	$12.7M	Buy	78,462 +2,108	+3%	+$306K	0.75%	26
2021 Q4	$10.3M	Buy	76,354 +2,474	+3%	+$292K	0.61%	33
2021 Q3	$7.97M	Buy	73,880 +3,819	+5%	+$436K	0.53%	40
2021 Q2	$7.89M	Buy	70,061 +2,855	+4%	+$322K	0.58%	35
2021 Q1	$7.27M	Buy	67,206 +5,462	+9%	+$584K	0.66%	29
2020 Q4	$6.62M	Buy	61,744 +8,801	+17%	+$846K	0.73%	24
2020 Q3	$4.64M	Sell	52,943 -8,899	-14%	-$838K	0.59%	38
2020 Q2	$6.07M	Sell	61,842 -10,806	-15%	-$951K	0.71%	32
2020 Q1	$5.54M	Buy	72,648 +18,482	+34%	+$1.57M	1.08%	18
2019 Q4	$4.8M	Buy	+54,166	New	+$4.5M	0.65%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Integrated Advisors Network's ABBV Position: Q2 2026 in Review

Integrated Advisors Network reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $164K and leaving 46,747 shares worth $11.8M. The position accounts for 0.54% of the portfolio, ranked #38.

Integrated Advisors Network first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.7M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Integrated Advisors Network held 46,747 shares of AbbVie worth $11.8M as of Q2 2026.
Integrated Advisors Network sold 762 AbbVie shares in Q2 2026, an estimated $164K.
AbbVie made up 0.54% of Integrated Advisors Network's portfolio in Q2 2026, its #38 holding.
Integrated Advisors Network first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
Integrated Advisors Network's AbbVie position peaked at $12.7M in Q1 2022.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Integrated Advisors Network's 13F filing for Q2 2026, filed 11 Aug 2026.